Full name
"FORTO" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
68.20.Z - Rental and management of own or leased real estate
73 - Advertising, market research and public relations
85 - Education
86 - Healthcare
96.0 - Individual service activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -0,3 | -0,2 | 0 | 100 |
EBITDA | -0,3 | -0,2 | 0 | 100 |
Short time liabilities | 30,1 | 11,6 | 0 | -100 |
Equity capital | 4,3 | 4,1 | 4,1 | 0 |
Operating profit (EBIT) | -0,3 | -0,2 | 0 | 100 |
Assets | 34,4 | 15,7 | 4,1 | -74 |
Net profit (loss) | -0,3 | -0,2 | 0 | 100 |
Cash | 2,4 | 15,7 | 4,1 | -74 |
Liabilities and provisions for liabilities | 30,1 | 11,6 | 0 | -100 |
Net income from sale | 86,2 | 81,6 | 0 | -100 |
Working assets | 34,4 | 15,7 | 4,1 | -74 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -6,2 | -6 | 0 | 6 |
Equity capital to total assets | 12,6 | 26 | 100 | 74 |
Gross profit margin | -0,3 | -0,3 | 0 | |
EBITDA Margin | -0,3 | -0,3 | 0 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 127 | 52 | 0 | -52 |
Current financial liquidity indicator | 1.1435986757278442 | 1.3509690761566162 | 0,3 | |
Net dept to EBITDA | 9.205240249633789 | 63.8807258605957 | 54,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane